Liquidia (NASDAQ:LQDA) Director Stephen Bloch Sells 82,736 Shares

Liquidia Corporation (NASDAQ:LQDA) Director Stephen Bloch sold 82,736 shares of Liquidia stock in a transaction on Thursday, June 4th. The shares were sold at an average price of $64.97, for a total value of $5,375,357.92. Following the completion of the transaction, the director owned 1,787,306 shares of the company’s stock, valued at approximately $116,121,270.82. This trade represents a 4.42% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Liquidia Stock Performance

Shares of NASDAQ LQDA traded up $2.05 during mid-day trading on Monday, hitting $63.90. The company had a trading volume of 3,158,786 shares, compared to its average volume of 1,717,868. The company has a market capitalization of $5.68 billion, a price-to-earnings ratio of 456.46 and a beta of 0.58. Liquidia Corporation has a 1 year low of $11.85 and a 1 year high of $66.78. The company has a current ratio of 2.22, a quick ratio of 2.03 and a debt-to-equity ratio of 1.18. The stock’s 50-day moving average price is $46.78 and its 200-day moving average price is $39.64.

Liquidia (NASDAQ:LQDA) last posted its quarterly earnings data on Monday, May 11th. The company reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.41 by $0.11. The company had revenue of $132.87 million during the quarter, compared to analyst estimates of $119.44 million. Liquidia had a return on equity of 46.82% and a net margin of 7.74%.The company’s quarterly revenue was up 4187.1% compared to the same quarter last year. On average, sell-side analysts forecast that Liquidia Corporation will post 2.97 earnings per share for the current year.

Institutional Investors Weigh In On Liquidia

Several hedge funds have recently added to or reduced their stakes in the company. Covestor Ltd lifted its stake in Liquidia by 41.9% during the fourth quarter. Covestor Ltd now owns 1,216 shares of the company’s stock worth $42,000 after purchasing an additional 359 shares during the last quarter. PNC Financial Services Group Inc. lifted its stake in Liquidia by 7.2% during the fourth quarter. PNC Financial Services Group Inc. now owns 6,304 shares of the company’s stock worth $217,000 after purchasing an additional 422 shares during the last quarter. Quantinno Capital Management LP lifted its stake in Liquidia by 3.6% during the first quarter. Quantinno Capital Management LP now owns 17,165 shares of the company’s stock worth $648,000 after purchasing an additional 589 shares during the last quarter. Northwestern Mutual Wealth Management Co. bought a new stake in Liquidia during the fourth quarter worth about $25,000. Finally, ProShare Advisors LLC lifted its stake in Liquidia by 7.1% during the fourth quarter. ProShare Advisors LLC now owns 11,756 shares of the company’s stock worth $405,000 after purchasing an additional 775 shares during the last quarter. Institutional investors own 64.54% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on LQDA shares. Zacks Research raised Liquidia from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, May 5th. Raymond James Financial reissued a “strong-buy” rating and set a $68.00 price objective on shares of Liquidia in a research note on Thursday. Oppenheimer set a $75.00 price objective on Liquidia in a research note on Friday. Wells Fargo & Company lifted their price target on Liquidia from $51.00 to $62.00 and gave the stock an “overweight” rating in a research note on Tuesday, May 12th. Finally, BTIG Research lifted their price target on Liquidia from $50.00 to $59.00 and gave the stock a “buy” rating in a research note on Monday, May 11th. Three investment analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and two have issued a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $55.63.

Liquidia Company Profile

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).